Comparison Between Digital Nerve Microanastomosis and Traction Neurectomy in Post-Digital Amputat… (NCT07102654) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Comparison Between Digital Nerve Microanastomosis and Traction Neurectomy in Post-Digital Amputation Pain
50 participantsStarted 2025-12-01
Plain-language summary
The goal of this prospective observational study is to assess the post-operative pain in adults with digital amputation following two different surgical interventions: microanastomosis of digital nerves or traction neurectomy. The main questions it aims to answer are:
* Which surgical intervention results in less post-operative pain?
* Which surgical intervention leads to fewer symptoms after six months?
* Which surgical intervention is associated with fewest post-operative complications? Participants will complete a Visual Analog Scale (VAS) to assess the pain and the Disabilities of the Arm, Shoulder and Hand Questionnaire (DASH) to evaluate the disabilities.
The researchers will assess post-operative complications during follow-up appointments.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age ≥ 18 years
* Patients who have undergone a traumatic digital amputation
* Patients treated with one of the two following techniques: microanastomosis of digital nerves or traction neurectomy
* Postoperative follow-up of at least 6 months
Exclusion Criteria:
* Patients treated with a surgical intervention other than microanastomosis of digital nerves or traction neurectomy for digital amputation
* Non-traumatic amputations (e.g., cancer or infection)
* Follow-up of less than 6 months
* Patients with pre-existing peripheral neuropathy
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Postoperative Pain Measured by Visual Analog Scale in Adult Patients Following Digital Amputation
Timeframe: 1 week, 4 weeks and 6 months
2
Postoperative Symptoms Measured by the Disabilities of the Arm, Shoulder and Hand Questionnaire in Adult Patients Following Digital Amputation
Timeframe: 6 months
Trial details
NCT IDNCT07102654
SponsorCentre hospitalier de l'Université de Montréal (CHUM)